Inefficient halogenation and alkylation steps in fine chemical production lead to low yields and high waste. These processes control specific substitution pathways to ensure high-purity fluorinated intermediates.
Conventional aromatic substitution often suffers from poor yield and lack of positional control in complex aryl structures. Achieving precise functionalization at specific carbon sites enables the production of high-purity pharmaceutical intermediates.